-
Get ready for wider availability of the OraQuick HIV-1/2 rapid HIV test: with a June 2004 waiver issued by the Food and Drug Administration (FDA), the test now can be used by more than 180,000 sites in the United States, including outreach clinics, community-based organizations, and physicians offices.
-
The 18-year-old patient before you, scheduled for an annual exam, is sexually active and admits that condoms are not always used. What is your next move? If the patient is female, chances are she will be tested for chlamydia, but if the patient is male and asymptomatic, your practice may not include a routine screen for the sexually transmitted disease (STD). New research may have you rethink your approach.
-
The NIH has halted the estrogen-alone wing of the Womens Health Initiative a year before its scheduled end.
-
-
-
Intranasal fluticasone helps sleep-disordered breathing in patients with allergic rhinitis.
-
The FDA has approved a combination of olanzapine and fluoxetine for the treatment of depressive episodes associated with bipolar disorder.
-
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera; Coronary Artery Calcium Score Plus Framingham Score for Risk Prediction; Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis
-
-
Use of antibiotics is associated with increased risk of breast cancer and death from breast cancer in a dose-dependent way.